Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 13 studies | 23% ± 4% | |
type I pneumocyte | 9 studies | 26% ± 10% | |
ciliated cell | 7 studies | 28% ± 12% | |
endothelial cell of lymphatic vessel | 7 studies | 32% ± 12% | |
endothelial cell of artery | 5 studies | 18% ± 2% | |
epithelial cell | 5 studies | 36% ± 16% | |
basal cell | 5 studies | 31% ± 9% | |
glutamatergic neuron | 3 studies | 29% ± 2% | |
astrocyte | 3 studies | 22% ± 3% |
Insufficient scRNA-seq data for expression of FZD6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2161.27 | 1445 / 1445 | 99% | 102.47 | 181 / 183 |
ovary | 100% | 1202.76 | 180 / 180 | 97% | 48.38 | 419 / 430 |
lung | 100% | 1971.43 | 577 / 578 | 97% | 74.50 | 1125 / 1155 |
thymus | 100% | 2731.03 | 653 / 653 | 97% | 62.48 | 585 / 605 |
prostate | 100% | 1584.31 | 245 / 245 | 94% | 32.14 | 472 / 502 |
bladder | 100% | 2172.62 | 21 / 21 | 94% | 51.47 | 473 / 504 |
pancreas | 99% | 1106.52 | 326 / 328 | 93% | 30.94 | 166 / 178 |
uterus | 100% | 1468.35 | 170 / 170 | 91% | 69.81 | 418 / 459 |
intestine | 100% | 1292.35 | 966 / 966 | 90% | 26.03 | 473 / 527 |
breast | 100% | 2277.20 | 459 / 459 | 88% | 51.39 | 989 / 1118 |
stomach | 100% | 1236.45 | 358 / 359 | 87% | 26.35 | 249 / 286 |
kidney | 99% | 1203.19 | 88 / 89 | 88% | 30.32 | 792 / 901 |
skin | 100% | 3390.28 | 1809 / 1809 | 77% | 40.11 | 364 / 472 |
adrenal gland | 100% | 1683.13 | 258 / 258 | 65% | 14.35 | 149 / 230 |
adipose | 100% | 2371.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 80.17 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.09 | 1 / 1 |
blood vessel | 100% | 2180.54 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 772.18 | 832 / 861 | 0% | 0 | 0 / 0 |
spleen | 95% | 692.74 | 230 / 241 | 0% | 0 | 0 / 0 |
brain | 73% | 421.91 | 1927 / 2642 | 19% | 4.50 | 135 / 705 |
liver | 33% | 145.00 | 74 / 226 | 30% | 7.15 | 122 / 406 |
lymph node | 0% | 0 | 0 / 0 | 28% | 5.06 | 8 / 29 |
muscle | 26% | 125.62 | 206 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 24% | 4.69 | 19 / 80 |
peripheral blood | 17% | 165.75 | 162 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035880 | Biological process | embryonic nail plate morphogenesis |
GO_1904693 | Biological process | midbrain morphogenesis |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0030168 | Biological process | platelet activation |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0033278 | Biological process | cell proliferation in midbrain |
GO_0001843 | Biological process | neural tube closure |
GO_0001942 | Biological process | hair follicle development |
GO_0042472 | Biological process | inner ear morphogenesis |
GO_0048105 | Biological process | establishment of body hair planar orientation |
GO_0060071 | Biological process | Wnt signaling pathway, planar cell polarity pathway |
GO_0035567 | Biological process | non-canonical Wnt signaling pathway |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0009986 | Cellular component | cell surface |
GO_0016327 | Cellular component | apicolateral plasma membrane |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0017147 | Molecular function | Wnt-protein binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042813 | Molecular function | Wnt receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FZD6 |
Protein name | Frizzled class receptor 6 Frizzled-6 (Fz-6) (hFz6) Frizzled-6 |
Synonyms | hCG_15041 |
Description | FUNCTION: Receptor for Wnt proteins. Most of frizzled receptors are coupled to the beta-catenin canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. Together with FZD3, is involved in the neural tube closure and plays a role in the regulation of the establishment of planar cell polarity (PCP), particularly in the orientation of asymmetric bundles of stereocilia on the apical faces of a subset of auditory and vestibular sensory cells located in the inner ear (By similarity). . |
Accessions | ENST00000521195.1 E5RJT4 ENST00000358755.5 [O60353-1] G5EA13 E5RJG0 ENST00000522566.5 [O60353-1] ENST00000522484.5 ENST00000519011.5 E5RGK8 ENST00000523739.5 [O60353-2] ENST00000523933.5 O60353 |